Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 6, 2007, Pages 436-441

  Pirro, Matteo ^a   Schillaci, Giuseppe ^a   Mannarino, Massimo Raffaele ^a   Savarese, Gianluca ^a   Vaudo, Gaetano ^a   Siepi, Donatella ^a   Paltriccia, Rita ^a   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Arterial stiffness; Nitrotyrosine; Statin

Indexed keywords

3 NITROTYROSINE; 3-NITROTYROSINE; CHOLESTEROL; DRUG DERIVATIVE; FLUOROBENZENE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; ROSUVASTATIN; SULFONAMIDE; TYROSINE; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA; ARTICLE; BLOOD; CLINICAL TRIAL; COMPLIANCE (PHYSICAL); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LOW FAT DIET; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; PULSATILE FLOW; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AORTA; CHOLESTEROL; COMBINED MODALITY THERAPY; COMPLIANCE; DIET, FAT-RESTRICTED; FEMALE; FLUOROBENZENES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULSATILE FLOW; PYRIMIDINES; SULFONAMIDES; TREATMENT OUTCOME; TYROSINE;

EID: 34447525009     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.02.009     Document Type: Article

References (18)

1. Tsiara S., Elisaf M., and Mikhailidis D.P. Early vascular benefits of statin therapy. Curr Med Res Opin 19 (2003) 540-556
2. O'Driscoll G., Green D., and Taylor R.R. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 95 (1997) 1126-1131
3. Marchesi S., Lupattelli G., Siepi D., Schillaci G., Vaudo G., Roscini A.R., et al. Short-term atorvastatin treatment improves endothelial function in hypercholesterolemic women. J Cardiovasc Pharmacol 36 (2000) 617-621
4. Kugi M., Matsunaga A., Ono J., Arakawa K., and Sasaki J. Antioxidative effects of fluvastatin on superoxide anion activated by angiotensin II in human aortic smooth muscle cells. Cardiovasc Drugs Ther 16 (2002) 203-207
5. Laufs U., Gertz K., Dirnagl U., Bohm M., Nickenig G., and Endres M. Rosuvastatin, a new HMG-CoA reductase inhibitor, upregulates endothelial nitric oxide synthase and protects from ischaemic stroke in mice. Brain Res 942 (2002) 23-30
6. Riesen W.F., Enger H., Risch M., Korte M., and Noseda G. Short term effects of atorvastatin on C-reactive protein. Eur Heart J 23 (2002) 761-764
7. Beckman J.S., and Koppenol W.H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271 (1996) 1424-1437
8. Boutouyrie P., Tropeano A.I., Asmar R., Gautier I., Benetos A., Lacolley P., et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 39 (2002) 10-15
9. Laurent S., Boutouyrie P., Asmar R., Gautier I., Laloux B., Guize L., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
10. Kontopoulos A.G., Athyros V.G., Pehlivanidis A.N., Demitriadis D.S., Papageorgiou A.A., and Boudoulas H. Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients. Curr Med Res Opin 19 (2003) 22-27
11. Raison J., Rudnichi A., and Safar M.E. Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study. J Hum Hypertens 16 (2002) 705-710
12. Van Doornum S., McColl G., and Wicks I.P. Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. Ann Rheum Dis 63 (2004) 1571-1575
13. Jones P.H., Davidson M.H., Stein E.A., Bays H.E., McKenney J.M., Miller E., et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). Am J Cardiol 92 (2003) 152-160
14. Pirro M., Schillaci G., Savarese G., Gemelli F., Vaudo G., Siepi D., et al. Low-grade systemic inflammation impairs arterial stiffness in newly diagnosed hypercholesterolaemia. Eur J Clin Invest 34 (2004) 335-341
15. Pirro M., Schillaci G., Savarese G., Gemelli F., Vaudo G., Siepi D., et al. Attenuation of inflammation with short-term dietary intervention is associated with a reduction of arterial stiffness in subjects with hypercholesterolemia. Eur J Cardiovasc Prev Rehabil 11 (2004) 497-502
16. Lu T.M., Ding Y.A., Leu H.B., Yin W.H., Sheu W.H., and Chu K.M. Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia. Am J Cardiol 94 (2004) 157-161
17. Nigam A., Mitchell G.F., Lambert J., and Tardif J.C. Relation between conduit vessel stiffness (assessed by tonometry) and endothelial function (assessed by flow-mediated dilatation) in patients with and without coronary heart disease. Am J Cardiol 92 (2003) 395-399
18. Guerin A.P., Blacher J., Pannier B., Marchais S.J., Safar M.E., and London G.M. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103 (2001) 987-992